Haemophilus Influenzae Type B Vaccine Market 2027 by Type, Formulation, Application | The Insight Partners

Haemophilus Influenzae Type B Vaccine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (HIB Vaccine, DTaP-IPV); Formulation (Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB, Lyophilized Combination HIB); Application (Hospital, Research and Academic Labs, Pharmaceuticals and Biotechnology Companies, Others)

Report Code: TIPRE00008513 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

The Haemophilus influenzae type B vaccine often called the Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b infection. Haemophilus influenzae type b (Hib) disease is a severe disease caused by bacteria. It usually affects children under five years old. It can also affect adults with certain medical conditions. YThe germs spread from person to person. If the germs stay in the child's nose and throat, the child probably will not get sick. But sometimes the germs spread into the lungs or the bloodstream, and then Hib can cause serious problems. This is called invasive Hib disease.

MARKET DYNAMICS

The haemophilus influenzae type B vaccine market is anticipated to grow owing to the increase in healthcare initiatives and the rise in diseases among infants. Moreover, an increasing number of HIB cases worldwide have made these vaccines a regularized immunization program, resulting in an increase in demand for the product in both developed as well as developing countries is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Haemophilus Influenzae Type B Vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in haemophilus influenzae type B vaccine market with detailed market segmentation by type, formulation, application and geography. The haemophilus influenzae type B vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in haemophilus influenzae type B vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The haemophilus influenzae type B vaccine market is segmented on the basis of type, formulation and application. Based on type the market is segmented as HIB vaccine and DTaP-IPV. On the basis of formulation the market is categorized as liquid monovalent HIB, liquid combination HIB, lyophilized monovalent HIB and lyophilized combination HIB. On the basis of application the market is categorized as hospital, research and academic labs, pharmaceuticals and biotechnology companies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in haemophilus influenzae type B vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The haemophilus influenzae type B vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting haemophilus influenzae type B vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the haemophilus influenzae type B vaccine market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in haemophilus influenzae type B vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in haemophilus influenzae type B vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in haemophilus influenzae type B vaccine market in the global market. Below mentioned is the list of few companies engaged in the haemophilus influenzae type B vaccine market.

The report also includes the profiles of key in haemophilus influenzae type B vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- GlaxoSmithKline plc
- Lanzhou Institute Of Biological Products Co., Ltd.
- McKesson Corporation
- Medline Industries, Inc.
- Merck Sharp & Dohme Corp.
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Walvax Biotechnology Co., Ltd.
- Weldon Biotech, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Haemophilus Influenzae Type B Vaccine Market - By Type
1.3.2 Haemophilus Influenzae Type B Vaccine Market - By Formulation
1.3.3 Haemophilus Influenzae Type B Vaccine Market - By Application
1.3.4 Haemophilus Influenzae Type B Vaccine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. HAEMOPHILUS INFLUENZAE TYPE B VACCINE - GLOBAL MARKET OVERVIEW
6.2. HAEMOPHILUS INFLUENZAE TYPE B VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HIB VACCINE
7.3.1. Overview
7.3.2. HIB Vaccine Market Forecast and Analysis
7.4. DTAP-IPV
7.4.1. Overview
7.4.2. DTaP-IPV Market Forecast and Analysis
8. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - FORMULATION
8.1. OVERVIEW
8.2. FORMULATION MARKET FORECASTS AND ANALYSIS
8.3. LIQUID MONOVALENT HIB
8.3.1. Overview
8.3.2. Liquid Monovalent HIB Market Forecast and Analysis
8.4. LIQUID COMBINATION HIB
8.4.1. Overview
8.4.2. Liquid Combination HIB Market Forecast and Analysis
8.5. LYOPHILIZED MONOVALENT HIB
8.5.1. Overview
8.5.2. Lyophilized Monovalent HIB Market Forecast and Analysis
8.6. LYOPHILIZED COMBINATION HIB
8.6.1. Overview
8.6.2. Lyophilized Combination HIB Market Forecast and Analysis
9. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. RESEARCH AND ACADEMIC LABS
9.4.1. Overview
9.4.2. Research and Academic Labs Market Forecast and Analysis
9.5. PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES
9.5.1. Overview
9.5.2. Pharmaceuticals and Biotechnology Companies Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Haemophilus Influenzae Type B Vaccine Market Overview
10.1.2 North America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis
10.1.3 North America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Type
10.1.4 North America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Formulation
10.1.5 North America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Application
10.1.6 North America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Haemophilus Influenzae Type B Vaccine Market
10.1.6.1.1 United States Haemophilus Influenzae Type B Vaccine Market by Type
10.1.6.1.2 United States Haemophilus Influenzae Type B Vaccine Market by Formulation
10.1.6.1.3 United States Haemophilus Influenzae Type B Vaccine Market by Application
10.1.6.2 Canada Haemophilus Influenzae Type B Vaccine Market
10.1.6.2.1 Canada Haemophilus Influenzae Type B Vaccine Market by Type
10.1.6.2.2 Canada Haemophilus Influenzae Type B Vaccine Market by Formulation
10.1.6.2.3 Canada Haemophilus Influenzae Type B Vaccine Market by Application
10.1.6.3 Mexico Haemophilus Influenzae Type B Vaccine Market
10.1.6.3.1 Mexico Haemophilus Influenzae Type B Vaccine Market by Type
10.1.6.3.2 Mexico Haemophilus Influenzae Type B Vaccine Market by Formulation
10.1.6.3.3 Mexico Haemophilus Influenzae Type B Vaccine Market by Application
10.2. EUROPE
10.2.1 Europe Haemophilus Influenzae Type B Vaccine Market Overview
10.2.2 Europe Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis
10.2.3 Europe Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Type
10.2.4 Europe Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Formulation
10.2.5 Europe Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Application
10.2.6 Europe Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Haemophilus Influenzae Type B Vaccine Market
10.2.6.1.1 Germany Haemophilus Influenzae Type B Vaccine Market by Type
10.2.6.1.2 Germany Haemophilus Influenzae Type B Vaccine Market by Formulation
10.2.6.1.3 Germany Haemophilus Influenzae Type B Vaccine Market by Application
10.2.6.2 France Haemophilus Influenzae Type B Vaccine Market
10.2.6.2.1 France Haemophilus Influenzae Type B Vaccine Market by Type
10.2.6.2.2 France Haemophilus Influenzae Type B Vaccine Market by Formulation
10.2.6.2.3 France Haemophilus Influenzae Type B Vaccine Market by Application
10.2.6.3 Italy Haemophilus Influenzae Type B Vaccine Market
10.2.6.3.1 Italy Haemophilus Influenzae Type B Vaccine Market by Type
10.2.6.3.2 Italy Haemophilus Influenzae Type B Vaccine Market by Formulation
10.2.6.3.3 Italy Haemophilus Influenzae Type B Vaccine Market by Application
10.2.6.4 Spain Haemophilus Influenzae Type B Vaccine Market
10.2.6.4.1 Spain Haemophilus Influenzae Type B Vaccine Market by Type
10.2.6.4.2 Spain Haemophilus Influenzae Type B Vaccine Market by Formulation
10.2.6.4.3 Spain Haemophilus Influenzae Type B Vaccine Market by Application
10.2.6.5 United Kingdom Haemophilus Influenzae Type B Vaccine Market
10.2.6.5.1 United Kingdom Haemophilus Influenzae Type B Vaccine Market by Type
10.2.6.5.2 United Kingdom Haemophilus Influenzae Type B Vaccine Market by Formulation
10.2.6.5.3 United Kingdom Haemophilus Influenzae Type B Vaccine Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Overview
10.3.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Formulation
10.3.5 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Haemophilus Influenzae Type B Vaccine Market
10.3.6.1.1 Australia Haemophilus Influenzae Type B Vaccine Market by Type
10.3.6.1.2 Australia Haemophilus Influenzae Type B Vaccine Market by Formulation
10.3.6.1.3 Australia Haemophilus Influenzae Type B Vaccine Market by Application
10.3.6.2 China Haemophilus Influenzae Type B Vaccine Market
10.3.6.2.1 China Haemophilus Influenzae Type B Vaccine Market by Type
10.3.6.2.2 China Haemophilus Influenzae Type B Vaccine Market by Formulation
10.3.6.2.3 China Haemophilus Influenzae Type B Vaccine Market by Application
10.3.6.3 India Haemophilus Influenzae Type B Vaccine Market
10.3.6.3.1 India Haemophilus Influenzae Type B Vaccine Market by Type
10.3.6.3.2 India Haemophilus Influenzae Type B Vaccine Market by Formulation
10.3.6.3.3 India Haemophilus Influenzae Type B Vaccine Market by Application
10.3.6.4 Japan Haemophilus Influenzae Type B Vaccine Market
10.3.6.4.1 Japan Haemophilus Influenzae Type B Vaccine Market by Type
10.3.6.4.2 Japan Haemophilus Influenzae Type B Vaccine Market by Formulation
10.3.6.4.3 Japan Haemophilus Influenzae Type B Vaccine Market by Application
10.3.6.5 South Korea Haemophilus Influenzae Type B Vaccine Market
10.3.6.5.1 South Korea Haemophilus Influenzae Type B Vaccine Market by Type
10.3.6.5.2 South Korea Haemophilus Influenzae Type B Vaccine Market by Formulation
10.3.6.5.3 South Korea Haemophilus Influenzae Type B Vaccine Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Overview
10.4.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Formulation
10.4.5 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Haemophilus Influenzae Type B Vaccine Market
10.4.6.1.1 South Africa Haemophilus Influenzae Type B Vaccine Market by Type
10.4.6.1.2 South Africa Haemophilus Influenzae Type B Vaccine Market by Formulation
10.4.6.1.3 South Africa Haemophilus Influenzae Type B Vaccine Market by Application
10.4.6.2 Saudi Arabia Haemophilus Influenzae Type B Vaccine Market
10.4.6.2.1 Saudi Arabia Haemophilus Influenzae Type B Vaccine Market by Type
10.4.6.2.2 Saudi Arabia Haemophilus Influenzae Type B Vaccine Market by Formulation
10.4.6.2.3 Saudi Arabia Haemophilus Influenzae Type B Vaccine Market by Application
10.4.6.3 U.A.E Haemophilus Influenzae Type B Vaccine Market
10.4.6.3.1 U.A.E Haemophilus Influenzae Type B Vaccine Market by Type
10.4.6.3.2 U.A.E Haemophilus Influenzae Type B Vaccine Market by Formulation
10.4.6.3.3 U.A.E Haemophilus Influenzae Type B Vaccine Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Haemophilus Influenzae Type B Vaccine Market Overview
10.5.2 South and Central America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Type
10.5.4 South and Central America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Formulation
10.5.5 South and Central America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Application
10.5.6 South and Central America Haemophilus Influenzae Type B Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Haemophilus Influenzae Type B Vaccine Market
10.5.6.1.1 Brazil Haemophilus Influenzae Type B Vaccine Market by Type
10.5.6.1.2 Brazil Haemophilus Influenzae Type B Vaccine Market by Formulation
10.5.6.1.3 Brazil Haemophilus Influenzae Type B Vaccine Market by Application
10.5.6.2 Argentina Haemophilus Influenzae Type B Vaccine Market
10.5.6.2.1 Argentina Haemophilus Influenzae Type B Vaccine Market by Type
10.5.6.2.2 Argentina Haemophilus Influenzae Type B Vaccine Market by Formulation
10.5.6.2.3 Argentina Haemophilus Influenzae Type B Vaccine Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HAEMOPHILUS INFLUENZAE TYPE B VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MCKESSON CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MEDLINE INDUSTRIES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK SHARP AND DOHME CORP.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WALVAX BIOTECHNOLOGY CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WELDON BIOTECH, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc
2. Lanzhou Institute of Biological Products Co., Ltd.
3. McKesson Corporation
4. Medline Industries, Inc.
5. Merck Sharp & Dohme Corp.
6. Novartis AG
7. Sanofi
8. Takeda Pharmaceutical Company Limited
9. Walvax Biotechnology Co., Ltd.
10. Weldon Biotech, Inc.
TIPRE00008513
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking